Ibuprofen extended-release capsules

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects. It is a sustained-release dosage form that allows the drug to be gradually released in the body. Each dose can provide continuous pain relief for 12 hours.

Each tablet of this product contains 0.3g of ibuprofen, the main ingredient. The auxiliary materials are: sugar, starch, stearic acid, polyvinyl pyrrolidone.

The contents of this product are white spherical pellets.

It is used to relieve mild to moderate pain such as headache, migraine, toothache, dysmenorrhea, joint pain, muscle pain, neuralgia, and also for fever caused by the common cold or influenza.

Oral administration: Adults, 1 tablet at a time, 2 times a day (morning and evening).

1. A small number of patients may experience nausea, vomiting, stomach burning or mild indigestion, gastrointestinal ulcers and bleeding, elevated transaminase, headache, dizziness, tinnitus, blurred vision, mental tension, drowsiness, lower limb edema or sudden weight gain. 2. Rarely, skin rash, allergic nephritis, cystitis, nephrotic syndrome, renal papillary necrosis or renal failure, bronchospasm.

1. It is contraindicated for those who are allergic to other non-steroidal anti-inflammatory drugs. 2. It is contraindicated for pregnant and lactating women. 3. It is contraindicated for asthmatics who are allergic to aspirin.

Precautions for children: Children must use under adult supervision. Precautions for pregnancy and lactation: Use with caution. Precautions for the elderly: Elderly patients are prone to adverse reactions due to decreased liver and kidney function, so they should be used with caution or in a reduced dosage.

1. When this product is used together with other antipyretic, analgesic and anti-inflammatory drugs, it may increase gastrointestinal adverse reactions and may cause ulcers. 2. When this product is used together with anticoagulants such as heparin and dicoumarol, it may lead to prolonged prothrombin time and increased bleeding tendency. 3. When this product is used together with digoxin, methotrexate, and oral hypoglycemic drugs, it can increase the blood concentration of these drugs and should not be used together. 4. When this product is used together with furosemide (furanosemic acid), the latter's excretion and antihypertensive effects are weakened; when used together with antihypertensive drugs, the latter's antihypertensive effect is also reduced. 5. If used with other drugs at the same time, drug interactions may occur. Please consult a physician or pharmacist for details.

Sealed storage

0.4 g

36 months

Sino-American Tianjin SmithKline and French Lab., Ltd.

• Founded in:

  1984-09-23

• Address:

  Chenglinzhuang Industrial Zone, Dongli District, Tianjin

• Tax NO.:

  9112011060055017XM

• Registered Funds:

  $29.94 million

• Email:

  Log in to view